Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in acute myocardial infarction
ISRCTN97018444Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- May 2003
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial of etanercept in myocardial infarction (MI) and acute coronary syndrome (ACS), sponsored by University of Edinburgh. Primary endpoints: Platelet-monocyte aggregation, Peripheral vasomotor function and 1 more. Started May 2003; status: completed.
02
Drugs
etanercept
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ISRCTN97018444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN97018444.